AFP
HALO icon

Ausdal Financial Partners’s Halozyme HALO Stock Holding History

Ausdal Financial Partners’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,678
Closed -$29K – 558
2015
Q4 		$29K Buy
+1,678
New +$26.7K 0.01% 608

Other funds holding HALO

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Ausdal Financial Partners's HALO Position: Q1 2016 in Review

Ausdal Financial Partners sold out of Halozyme (HALO) in Q1 2016, closing a stake of 1,678 shares — an estimated $29K sold.

Ausdal Financial Partners first reported a position in HALO in Q4 2015 and held it in 1 quarter. The position peaked at $29K in Q4 2015. 161 funds tracked by Wall St. Rank hold HALO as of Q1 2016.

  • Ausdal Financial Partners reported no remaining Halozyme position as of Q1 2016 after selling out during the quarter.
  • Ausdal Financial Partners sold 1,678 Halozyme shares in Q1 2016, an estimated $29K.
  • Ausdal Financial Partners first reported a position in Halozyme in Q4 2015 and held it in 1 quarter.
  • Ausdal Financial Partners's Halozyme position peaked at $29K in Q4 2015.
  • 161 funds tracked by Wall St. Rank held Halozyme as of Q1 2016.

Based on Ausdal Financial Partners's 13F filing for Q1 2016, filed 5 May 2016.